This webinar will provide education and information on the new MSCC Lung Cancer Pathway in Greater Manchester, East & Mid Cheshire.
The pathway will promote team working between MSCC Co-ordinators, Acute Oncology Nurses & Lung Cancer Nurses. It will promote importance of rapid pathological diagnosis before considering surgery, exclude small cell and look for better prognostic groups via ctDNA (high false positive rate) and tissue biopsy to look for drivers and obtain PDL1. For patients will no neurology and good performance status the priority is to quickly receive SACT and likely to offer radiotherapy. Patients will be considered on a case by case basis for surgery where no pathological diagnosis is possible, low comorbidity and spinal instability or potentially reversible / changing neurology affecting performance status for imminent SACT.
